Inclusion Criteria:~* Aged 70 years or older.~* Family history of parent, brother, or sister who has, or had,
serious age-related memory loss, senility, dementia, or Alzheimer's disease.~* Study partner available to
provide information on the cognitive status of the participant and to assist with monitoring of trial
medications, if needed.~* Sufficient fluency in written and spoken English to participate in study visits and
neuropsychological testing.~* Willingness to limit use of the following for the duration of the study: vitamin
E (at doses greater than 400 IU per day), non-aspirin NSAIDs, histamine H2 receptor antagonists (Tagamet, for
example), corticosteroids, anti-inflammatory or analgesic doses of aspirin (greater than 81 mg per day), Ginkgo
biloba extracts~* Ability and intention to participate in regular study visits, in the opinion of the study
physician.~* Provision of informed consent.~
